Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 64 citing Ader: Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying.... (0.07 sec) 

Endocrine and metabolic adverse effects of psychotropic medications in children …

- nursing2008.com
CU Correll, HE Carlson - Journal of Amer Academy of Child & …, 2006 - journals.lww.com
Dr. Correll is with the Zucker Hillside Hospital, North Shore-Long Island Jewish Health
System, and the Albert Einstein College of Medicine; Dr. Carlson is with the Department of
Medicine-Endocrinology Division, Stony Brook University Hospital.
Cited by 84 - Related articles - BL Direct - All 14 versions

A randomized, double-blind, placebo-controlled trial of metformin treatment of …

- psychiatryonline.org
DJ Klein, EM Cottingham, M Sorter, BA … - American Journal of …, 2006 - Am Psychiatric Assoc
OBJECTIVE: Second-generation, or atypical, antipsychotics effectively treat psychiatric illness
in children and adolescents. However, weight gain and abnormalities in insulin sensitivity, including
diabetes, complicate this therapy. METHOD: A 16-week double-blind, placebo-controlled ...
Cited by 70 - Related articles - BL Direct - All 6 versions

Recognizing and monitoring adverse events of second-generation antipsychotics …


CU Correll, JB Penzner, UH Parikh, T Mughal, T … - Child and Adolescent …, 2006 - Elsevier
Although second-generation antipsychotics (SGAs) are used increasingly in children and
adolescents, data on the effectiveness and safety in pediatric populations are still sparse. Much
of the safety information is derived from studies conducted in adults. This derivation is ...
Cited by 47 - Related articles - All 5 versions

Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: …


KL Houseknecht, AS Robertson, W Zavadoski, … - …, 2006 - nature.com
Although it is generally accepted that atypical antipsychotics differ in their risk for diabetic side
effects, the underlying pharmacological mechanisms are unknown. Studies on the mechanisms
of antipsychotic-induced hyperglycemia or insulin resistance are often confounded by the ...
Cited by 37 - Related articles - BL Direct - All 6 versions

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity …


AH Barnett, P Mackin, I Chaudhry, A Farooqi, … - Journal of …, 2007 - jop.sagepub.com
DOI: 10.1177/0269881107075509 2007; 21; 357 J Psychopharmacol TayLor, J. Vora and PB
Jones ... AH Barnett, P. Mackin, I. Chaudhry, A. Farooqi, R. Gadsby, A. Heald, J. Hill, H.
Millar, R. Peveler, A. Rees, V. Singh, D. Minimising metabolic and cardiovascular risk in ...
Cited by 31 - Related articles - BL Direct - All 5 versions

Effects of olanzapine in male rats: enhanced adiposity in the absence of …


GD Cooper, LC Pickavance, JPH Wilding, JA … - Journal of …, 2007 - jop.sagepub.com
Many of olanzapine's (OLZ) actions in humans related to weight regulation can be modelled
in female rats (Cooper et al., 2005). Such effects include weight gain, hyperphagia, enhanced
visceral adiposity and elevated levels of insulin and adiponectin. As sex differences have ...
Cited by 28 - Related articles - BL Direct - All 4 versions

The safety and tolerability of atypical antipsychotics in bipolar disorder


F Seemüller, A Forsthoff, S Dittmann, C … - Expert Opin. Drug …, 2005 - Informa Pharma Science
Atypical antipsychotics (aAPs), have become a first-line treatment option, both in schizophrenia
and bipolar disorders. Almost all aAPs now have proven efficacy in acute mania, some also in
bipolar depression and in main- tenance treatment. This provides reliable data on their ...
Cited by 21 - Related articles - BL Direct - All 4 versions

Abnormal glucose metabolism in patients treated with antipsychotics


AJ Scheen, MA De Hert - Diabetes and Metabolism, 2007 - Elsevier
Second-generation (atypical) antipsychotic medications are of great benefit to a wide variety
of people with psychiatric disorders, especially patients with schizophrenia. However, one constellation
of adverse effects is an increased risk of obesity, diabetes, and metabolic syndrome. ...
Cited by 22 - Related articles - BL Direct - All 5 versions

Food intake and reward mechanisms in patients with schizophrenia: implications …


I Elman, D Borsook, SE Lukas - Neuropsychopharmacology, 2006 - nature.com
Obesity is highly prevalent among patients with schizophrenia and is associated with detrimental
health consequences. Although excessive consumption of fast food and pharmacotherapy with
such second-generation antipsychotic agents (SGAs) as clozapine and olanzapine has ...
Cited by 20 - Related articles - BL Direct - All 6 versions

Antipsychotic drugs and diabetes—an application of the Austin Bradford Hill criteria


RIG Holt, RC Peveler - Diabetologia, 2006 - Springer
Abstract There is concern that antipsychotic drugs cause diabetes. Although there has been
an explosion in the quantity of literature about this subject, it remains confusing and
inconsistent. To assess whether the association between antipsychotic drugs and ...
Cited by 17 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google